← Every company
Revelation Biosciences Inc SEC Filings
What Revelation Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
REVB overview →Filings on file
106
since Jul 29, 2020
Warning signs
15
latest Jan 7, 2025
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 19, 2026 | Executive or director change 8-K | Read ↗ |
| Jun 24, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 28, 2025 | Executive or director change 8-K | Read ↗ |
| Oct 2, 2023 | Executive or director change 8-K | Read ↗ |
| Jan 14, 2022 | Executive or director changeAcquisition or sale completedChange in controlUnregistered share sale 8-K | Read ↗ |
| Mar 5, 2021 | Executive or director change 8-K/A | Read ↗ |
| Feb 23, 2021 | Executive or director change 8-K | Read ↗ |
Source: Revelation Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.